Results 141 to 150 of about 29,271 (207)

Acalabrutinib treatment in relapsed/refractory primary cutaneous diffuse large B cell lymphoma, leg type. Case report. [PDF]

Front Oncol
Martinez-Gamboa DA, Beas FF, Moreno-Cortes E, Swanson LA, Mangold AR, Vargas F, Castro JE.   +6 more
europepmc   +1 more source

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance) [PDF]

, 2018
Fehniger, Todd A.
core   +1 more source

Bruton’s tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia [PDF]

, 2018
AG Evans, B Mizukawa, FM Vega, G Pillinger, H Wu, HP Kuo, HS Kuehn, J Wei, K Bence, L Zaitseva, M Konopleva, MA Ayoub, MY Murray, R Schrage, S Tavor, SA Rushworth, SP Xu, T Oellerich, TL Gu   +18 more
core   +1 more source

Bruton Tyrosine Kinase Inhibition in Combination With Bispecific Antibodies for Richter's Syndrome: A Report of Two Cases and Mini Review. [PDF]

Cureus
Hane BC, Hoffmann M, Zhang D, Chopra S, Bennett J.   +4 more
europepmc   +1 more source

A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study.

Blood
Itsara A, Rogness VM, Samples L, Yuan CM, Wang HW, Ahn IE, Farooqui MZH, Tian X, Sun C, Tomasulo E, Soto S, Superata J, Bezkorovaynaya L, Hughes TE, Nierman P, Wiestner A.   +15 more
europepmc   +1 more source

Latest advances in frontline CLL treatment from the 2025 ASH congress. [PDF]

Ann Hematol
Visentin A.
europepmc   +1 more source

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia [PDF]

, 2015
Aymerich, Marta, Campo, Elías, Colomer, Dolors, Lagisetti, Chandraiah, López Guerra, Mónica, López Otín, Carlos, Montraveta, Arnau, Rodríguez, Vanina, Roldán, Jocabed, Rosich, Laia, Villamor Casas, Neus, Webb, Thomas R., Xargay-Torrent, Sçilvia   +12 more
core   +1 more source

CBX2 phase-separation contributes to homologous recombination repair and drug resistance in ovarian cancer. [PDF]

Cell Death Dis
Sun S, Huang L, Ma Y, Wei Z, Zhu M, Chen M, Ying F, Zhou X, Yang P, Wen Y, Yang Q, Cai L, Zhang Y, Cai J.   +13 more
europepmc   +1 more source

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia [PDF]

, 2017
C. J. Owen, C. L. Toze, C. Shustik, I. Bence-Bruckler, R. Delage, S. Coutre   +5 more
core   +1 more source

Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma. [PDF]

Blood Adv
Handunnetti SM, Khot A, Blombery P, Burbury K, Thompson PA, Ritchie D, Hicks RJ, Burke G, Koldej R, Bressel M, Di Iulio J, Westerman DA, Lade S, Roberts AW, Seymour JF, Tam CS, Anderson MA.   +16 more
europepmc   +1 more source